Renal Toxicities in Cancer Patients Receiving Immune-Checkpoint Inhibitors: A Meta-Analysis

Aim: We performed a meta-analysis of the available clinical trials of immune-checkpoint inhibitors to assess risk differences and relative risks of renal toxicity. Methods: 17 randomized phase III studies were selected, including 10,252 patients. Results: The administration of immune-checkpoint inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Righini, Matteo, Mollica, Veronica, Rizzo, Alessandro, La Manna, Gaetano, Massari, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368813/
https://www.ncbi.nlm.nih.gov/pubmed/35955989
http://dx.doi.org/10.3390/jcm11154373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368813/
https://www.ncbi.nlm.nih.gov/pubmed/35955989
http://dx.doi.org/10.3390/jcm11154373

Ejemplares similares